Neulasta

Latest stories

3d
Los Angeles Times
FDA approves Amgen cholesterol-lowering drug Repatha for some patientsThe U.S. Food and Drug Administration on Thursday approved Amgen Inc.’s cholest
FDA approves Amgen cholesterol-lowering drug Repatha for some patients
Los Angeles Times / Posted 3 days ago
The U.S. Food and Drug Administration on Thursday approved Amgen Inc.’s cholesterol-lowering drug Repatha, a promising medicine that could reduce heart disease and create billions of dollars in sales for the Thousand Oaks biotech giant. Repatha is... Read more
68 related stories
13d
Ventura County Star
Amgen paying $71M in off-label drug marketing caseNEW YORK (AP) — Biotech drugmaker Amgen will pay $71 million to settle an inves
Amgen paying $71M in off-label drug marketing case
Ventura County Star / Posted 13 days ago
NEW YORK (AP) — Biotech drugmaker Amgen will pay $71 million to settle an investigation into illegal marketing of its drugs Aranesp and Enbrel, ending an investigation by 48 states and Washington DC. Less than three years ago, Amgen agreed to pay... Read more
26 related stories
19d
PharmaceuticalOnline
Could Birth Of “Big Generic” Be Foreshadowing “Big Biosimilar”The past few weeks, the generics market has seen several players jump ship and
Could Birth Of “Big Generic” Be Foreshadowing “Big Biosimilar”
PharmaceuticalOnline / Posted 19 days ago
The past few weeks, the generics market has seen several players jump ship and one company grow significantly — and to some, alarmingly — larger. First to take the plunge was Allergan, which sold off its portfolio of generic drugs to goliath Teva for... Read more
1m
TheBull
Amgen hikes 2015 forecast after 2Q liftAmgen Inc shares have jumped in extended trading after the maker of osteoporosi
Amgen hikes 2015 forecast after 2Q lift
TheBull / Posted a month ago
Amgen Inc shares have jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's second-quarter profit expectations and raised its 2015 financial forecast. Amgen on Thursday said its net income rose to $US1.65... Read more
14 related stories
1m
San Antonio Express-News
Amgen hikes 2015 forecast after 2Q increase in profit, salesTRENTON, N.J. (AP) — Amgen Inc. shares jumped in extended trading after the mak
Amgen hikes 2015 forecast after 2Q increase in profit, sales
San Antonio Express-News / Posted a month ago
TRENTON, N.J. (AP) — Amgen Inc. shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's second-quarter profit expectations and hiked its 2015 financial forecast. Amgen, based in Thousand Oaks,... Read more
14 related stories
1m
Chattanooga Times Free Press
Amgen hikes 2015 forecast after 2Q increase in profit, salesTRENTON, N.J. (AP) - Amgen Inc. shares jumped in extended trading after the mak
Amgen hikes 2015 forecast after 2Q increase in profit, sales
Chattanooga Times Free Press / Posted a month ago
TRENTON, N.J. (AP) - Amgen Inc. shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's second-quarter profit expectations and hiked its 2015 financial forecast. Amgen, based in Thousand Oaks,... Read more
14 related stories
1m
Salon.com
Amgen hikes 2015 forecast after 2Q increase in profit, salesTRENTON, N.J. (AP) — Amgen Inc. shares jumped in extended trading after the mak
Amgen hikes 2015 forecast after 2Q increase in profit, sales
Salon.com / Posted a month ago
TRENTON, N.J. (AP) — Amgen Inc. shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street’s second-quarter profit expectations and hiked its 2015 financial forecast. Amgen, based in Thousand Oaks,... Read more
14 related stories
1m
Market Watch
Amgen raises 2015 outlook after earnings beatAmgen Inc. raised its 2015 guidance after reporting that its second-quarter ear
Amgen raises 2015 outlook after earnings beat
Market Watch / Posted a month ago
Amgen Inc. raised its 2015 guidance after reporting that its second-quarter earnings rose 6.9% on better-than-expected sales growth and lower operating expenses. For the year, the biotechnology company now expects per-share earnings of $9.55 to... Read more
14 related stories

People in this news